Groupama Asset Managment Invests $1.16 Million in Humana Inc. $HUM

Groupama Asset Managment purchased a new position in Humana Inc. (NYSE:HUMFree Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 4,808 shares of the insurance provider’s stock, valued at approximately $1,163,000.

Several other institutional investors and hedge funds have also bought and sold shares of the company. State Board of Administration of Florida Retirement System increased its holdings in Humana by 0.9% in the 2nd quarter. State Board of Administration of Florida Retirement System now owns 116,905 shares of the insurance provider’s stock valued at $28,581,000 after buying an additional 1,000 shares during the period. Elevation Point Wealth Partners LLC acquired a new stake in shares of Humana during the 2nd quarter worth approximately $32,000. Quadrant Capital Group LLC increased its stake in Humana by 159.2% in the second quarter. Quadrant Capital Group LLC now owns 4,533 shares of the insurance provider’s stock valued at $1,108,000 after acquiring an additional 2,784 shares during the last quarter. Choreo LLC increased its stake in Humana by 19.2% in the second quarter. Choreo LLC now owns 6,152 shares of the insurance provider’s stock valued at $1,510,000 after acquiring an additional 990 shares during the last quarter. Finally, Columbus Hill Capital Management L.P. raised its position in Humana by 24.7% during the second quarter. Columbus Hill Capital Management L.P. now owns 158,154 shares of the insurance provider’s stock valued at $38,665,000 after purchasing an additional 31,343 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on HUM. The Goldman Sachs Group reduced their target price on Humana from $235.00 to $215.00 and set a “sell” rating on the stock in a report on Monday, November 24th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Humana in a research note on Wednesday, October 8th. Bank of America boosted their target price on Humana from $280.00 to $300.00 and gave the stock a “neutral” rating in a research note on Friday, October 10th. Evercore ISI began coverage on shares of Humana in a report on Monday, September 22nd. They issued an “in-line” rating and a $295.00 target price for the company. Finally, Wells Fargo & Company lifted their price target on shares of Humana from $344.00 to $347.00 and gave the company an “overweight” rating in a report on Tuesday, October 7th. Eight research analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Humana has an average rating of “Hold” and a consensus target price of $295.94.

Get Our Latest Report on HUM

Humana Stock Performance

Humana stock opened at $245.77 on Friday. The business has a 50 day moving average of $263.19 and a 200-day moving average of $256.85. The company has a market capitalization of $29.56 billion, a P/E ratio of 18.86, a P/E/G ratio of 1.71 and a beta of 0.42. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $315.35. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95.

Humana (NYSE:HUMGet Free Report) last posted its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, topping the consensus estimate of $2.95 by $0.29. Humana had a net margin of 1.28% and a return on equity of 13.67%. The business had revenue of $32.65 billion for the quarter, compared to the consensus estimate of $31.99 billion. During the same period last year, the company earned $4.16 EPS. The firm’s revenue was up 11.1% compared to the same quarter last year. On average, equities research analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.4%. Humana’s payout ratio is currently 33.18%.

About Humana

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Stories

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.